No Data
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $92 Price Target
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $92
Barrington analyst Michael Petusky maintains $LeMaitre Vascular(LMAT.US)$ with a buy rating, and maintains the target price at $92.According to TipRanks data, the analyst has a success rate of 50.4%
Lemaitre Vascular's Growth Prospects Bolstered by Pricing Power and Strategic Expansion: A Buy Rating Review
Possible Bearish Signals With LeMaitre Vascular Insiders Disposing Stock
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
LeMaitre Vascular (NASDAQ:LMAT) Shareholders Have Earned a 25% CAGR Over the Last Five Years